Prescription drug · NDA
Licart (Diclofenac epolamine) NDC 71858-0305
Diclofenac epolamine .013 g/1 · System · Topical · IBSA Pharma Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71858-0305-2 | 71858030502 | 1 POUCH in 1 CARTON (71858-0305-2) / 2 SYSTEM in 1 POUCH (71858-0305-1)Marketed from Sep 1, 2020 · Sample package | |
| 71858-0305-5 | 71858030505 | 3 POUCH in 1 CARTON (71858-0305-5) / 5 SYSTEM in 1 POUCH (71858-0305-4)Marketed from Sep 1, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Licart
- Generic name (nonproprietary)
- diclofenac epolamine
- Active ingredients
- Diclofenac epolamine — .013 g/1
- Dosage form
- System
- Route
- Topical
- Labeler
- IBSA Pharma Inc.NDC labeler code 71858
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 206976
- Marketing start
- Listing expires
- Other FDA classes
- Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Prostaglandin Production (Physiologic effect)
- Identifiers
- Product ID 71858-0305_4e7d176c-1593-6214-e063-6394a90a4042SPL ID 4e7d176c-1593-6214-e063-6394a90a4042SPL set ID 851c8b39-6056-4bbc-812e-b9b13977c1acRxCUI 2372911, 2385117UNII X5F8EKL9ZG
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471858030502followed by a unit qualifier and the quantityPackage 71858-0305-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
LICART is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions in adults and pediatric patients 6 years of age and older. LICART contains diclofenac epolamine, which is a nonsteroidal anti-inflammatory drug (NSAID), and is indicated for the topical treatment of acute pain due to minor strains, sprains, and contusions in adults and pediatric patients 6 years and older. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 71858-0305
- What is NDC 71858-0305?
- 71858-0305 is the product NDC for Licart (diclofenac epolamine), Diclofenac epolamine .013 g/1 system, listed with the FDA by IBSA Pharma Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Licart (Diclofenac epolamine).
- What is the active ingredient?
- Diclofenac epolamine.
- Who is the labeler?
- IBSA Pharma Inc., NDC labeler code 71858. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Licart?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.